During the past decade, Wallace Medical Group, Inc. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wallace Medical Group, Inc." #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Horizon Therapeutics Ireland DAC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wallace Medical Group, Inc." #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Wallace Medical Group, Inc." are "Atopic Dermatitis" (8 trials), "Psoriasis" (2 trials), "Chronic Plaque Psoriasis" (1 trials), "Crohn Disease" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Wallace Medical Group, Inc." in a lesser frequency.

Most popular intervention types in "Wallace Medical Group, Inc." are "Drug" (12 trials), "Biological" (4 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Lebrikizumab" (5 trials), "Abrocitinib 200 mg" (2 trials), "Baricitinib" (2 trials) and "Abrocitinib 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wallace Medical Group, Inc." are 17 trials for "All" genders.

Currently, there are NaN active trials in "Wallace Medical Group, Inc.". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Wallace Medical Group, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wallace Medical Group, Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".